ACE inhibitors and statins are well tolerated in teenagers with type 1 diabetes but more evidence is required to demonstrate whether they are effective in preventing rapid increases in albumin excretion and associated complications leading to cardiovascular disease. According to the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT), the use of an ACE inhibitor, ...
Teens with diabetes cope with the additional burden of CV protection
By Mardi Chapman
9 Nov 2017